Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop.
Healthcare (Basel) September 12, 2025 Anna Schuldt, Ian C. Clark, Yasmin Schmid et al. 1 citation
Experts in palliative care, oncology, psychiatry, and psychedelic-assisted therapy identified special considerations for using psychedelics near the end of life. They emphasized a non-medicalized setting, the potential to reduce preparation time, and the importance of addressing anxiety, depression, and spiritual distress. Dosing flexibility was recommended: low-to-medium doses for relational issues, higher doses for transcendental experiences. Therapists need knowledge of mystical states, existential aspects of life-threatening illness, and their own inner work. The findings provide a first step toward specific treatment recommendations for psychedelic-assisted therapy in palliative care.